Precision Cancer Care for Pets

Name: OncoVet
Address: HK

We are revolutionizing pet oncology with personalized nano tumour vaccines and integrated precision treatment plans designed for the future of veterinary medicine - health span vs. life span.

Start Your Journey

Our Precision Solutions

Personalized Nano Tumour Vaccine

Pioneer of Whole Tumour Antigen vaccines with full coverage in targeting cancer cells while leaving healthy tissue unharmed, providing a tailored defense for every pet.

Learn More

Minimal Invasive Surgical Device

Advanced tools designed for high-precision interventions, reducing recovery times and minimizing trauma for your companion.

Learn More

Integrated Cancer Treatment Planning

Utilizing AI-driven diagnostics to create comprehensive, data-backed strategies for optimal cancer management.

Learn More

Cancer Treatment Training for Vets

Empowering veterinary professionals with the latest clinical expertise and hands-on training for advanced pet oncology.

Learn More

The Future of Precision Cancer Care

Personalized Nano Tumour Vaccines: Our patented vaccine engineered of Whole Tumour Antigen evokes comprehensive immune response, offering a tailored defense against cancer growth and recurrence with minimal side effects.

Integrated Cancer Planning: Seamlessly connect clinical data with advanced oncology science to design the most effective surgical and treatment pathways.

Minimal Invasive Surgical Tools: Precision-engineered ablative devices that provides safe, efficient results with reduce trauma and recovery time for our patients.

Latest News & Biotech Updates

Advancements in Precision Nano Tumour Vaccines

We are proud to announce the completion of our Phase 1 clinical trials in mice and progress of our Phase 2 clinical trials in human for the OncoVet Nano Tumour Vaccine, demonstrating a 60-100% cure rate in cases and cancer-free period of 3 years and above.

March 15, 2026

Integrated Cancer Planning Platform Launch

Our new Integrated Cancer Treatment Planning tool will be complimentary to the SurBlade™ Ablative Platform. This AI-driven platform allows pet owner and veterinary professionals to visualize tumor margins and predict treatment outcomes for Shared Decision-Making (SDM) collaborative approach .

May 28, 2026

Regional Exclusive Partnership 2026/27

Regional exclusive partnership program for 2026/27 is now open for registration. Join us to gain our latest research insights on personalized nano tumour vaccines, application and case study of SurBlateTM and sponsor funding for piloting cases. Together we bring the future of precision oncology for companion animals.

June 2, 2026

View All Insights

Revolutionizing Pet Cancer Care with Precision Biotechnology

We are at the forefront of personalized nano tumour vaccines and integrated surgical planning, providing veterinary professionals with the tools to deliver the most advanced precision cancer treatments for animals.